SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Thermo Electron (TMO)
TMO 565.49+0.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JakeStraw9/11/2009 9:36:22 AM
   of 450
 
Thermo Fisher Scientific Signs Agreement to Acquire Leading Provider of Specialty In-Vitro Diagnostic Tests - B.R.A.H.M.S. AG
finance.yahoo.com

B.R.A.H.M.S. is a leading provider of specialty in-vitro diagnostic tests based on its patented biomarkers for sepsis, cardiovascular and pulmonary diseases, as well as intensive care treatments and prenatal screening. The company is based outside of Berlin in Hennigsdorf, Germany, and has sales offices in Europe and the U.S. With approximately 400 employees serving customers in 65 countries around the world, B.R.A.H.M.S. generated 2008 revenues of €75 million (approximately $105 million USD). The transaction is expected to be accretive to earnings per share in 2010.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext